| Charles Schmidt |
Medial Expert |
MEDPACE BRASIL |
| Hendrik van den Berg |
Dutch Medicines Evaluation Board and Member |
PDCO |
| Michael Christiensen |
Senior Regulatory Affairs Project Manager |
Novo Nordisk |
| Dr Albert J Allen |
Senior Medical Director, Neuroscience Platform Team |
ELI LILLY |
| Dr Ensio Norjavaara |
Senior Research Physician Clinical Pharmacology |
Astrazeneca |
| Dr Luc De Schaepdrijver |
Research Fellow, Head of Reproductive/Juvenile and General Toxicology Late Development, Global Preclinical Development |
JOHNSON & JOHNSON PHARMACEUTICAL R&D |
| Liza Squires |
Research and Development Business Unit Leader |
SHIRE PHARMACEUTICAL DEVELOPMENT |
| Stephen Heaton |
Safety Risk Management Advisor for Pharmacovigilance |
BAYER HEALTHCARE |
| Peter Verdru |
Vice President Clinical Research, Therapeutic Area CNS |
UCB |
| Robert Webster |
Director, Global Research and Development, Pharmacokinetics, Dynamics and Metabolism |
PFIZER UK |
| Francis P Crawley |
Executive Director |
GOOD CLINICAL PRACTICE ALLIANCE – EUROPE |
| Hans Hoogland |
R&D Scientist, Regulatory Affairs Specialist |
LEO PHARMA |
| David Pierce |
Senior Clinical Pharmacology and Pharmacokinetics Director |
Senior Clinical Pharmacology and Pharmacokinetics Director |
| Jan Richter |
Global DRA Project Manager |
ACTELION PHARMACEUTICALS |
| Dr Nigel Roome |
Scientific Advisor, Global Drug Safety Evaluation |
SANOFI AVENTIS |
| Dr Philippe Auby |
Senior Medical Director Corporate ICR France and Paediatrics |
LUNDBECK |
| Sylvie Jouve |
Associate Director, Clinical Research and Development |
WYETH |
| Bruce Morland |
Consultant Paediatric Oncologist, Department of Oncology |
BIRMINGHAM CHILDREN’S HOSPITAL NHS TRUST |
| Dr Eric Hoedemaker |
Medical Director |
SANOFI AVENTIS |